APA (7th ed.) Citation

T, A., M, A., M, A., S, A., D, V., & M, S. (2025). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis. Current reviews in clinical and experimental pharmacology. https://doi.org/10.2174/0127724328373328250624065307

Chicago Style (17th ed.) Citation

T, Ahmad, Adil M, Azharuddin M, Ansari S, Vohora D, and Sharma M. "Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis." Current Reviews in Clinical and Experimental Pharmacology 2025. https://doi.org/10.2174/0127724328373328250624065307.

MLA (9th ed.) Citation

T, Ahmad, et al. "Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis." Current Reviews in Clinical and Experimental Pharmacology, 2025, https://doi.org/10.2174/0127724328373328250624065307.